Table 3 Pretreatment characteristics of HCV patients associated with Hb reduction ≥ 2 g/dl compared to pretreatment Hb value
Pretreatment characteristics of HCV patients | Odd ratio (95% CI) | P-value |
|---|---|---|
Age of patient | 1.07 (1.03–1.11) | 0.00 |
Patient gender | 0.59 (0.21–1.68) | 0.33 |
ITPA rs1127354 | 4.86 (1.79–13.2) | 0.00 |
ITPA rs7270101 | 0.63 (0.11–3.44) | 0.59 |
Body mass index | 0.89 (0.81–0.97) | 0.01 |
Viral load | 1.00 (1.00–1.00) | 0.34 |
White blood cell count | 1.05 (0.87–1.26) | 0.60 |
Red blood cell count (1012 /L) | 0.00 (0.00- 45.6) | 0.14 |
Hemoglobin | 71.9 (0.49–10,558) | 0.04 |
Platelet | 0.99 (0.98–1.0) | 0.15 |
Aspartate Aminotransferase | 1.013 (0.99–1.03) | 0.16 |
Alanine aminotransferase | 0.98 (0.96–1.00) | 0.18 |
Bilirubin (Total) | 0.24 (0.04–1.25) | 0.09 |
Serum creatinine | 0.43 (0.01–9.65) | 0.59 |
Serum urea | 0.92 (0.83–1.02) | 0.11 |